Skip to main content
SpringerLink
Log in

Antipsychotika

  • Chapter
Kompendium der Psychiatrischen Pharmakotherapie

  • 3782 Accesses

Zusammenfassung

Antipsychotika sind eine chemisch heterogene Gruppe von Pharmaka mit antipsychotischem Wirksamkeitsschwerpunkt und unterschiedlichem NW-Profil. Der häufig synonym verwendete Begriff »Neuroleptikum« wird international immer mehr durch den Begriff Antipsychotikum ersetzt. Dieser weist auf die klinisch bedeutsame therapeutische Wirkung bei psychotischen Störungen, insbesondere schizophrenen Psychosen, hin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Addington DE, Mohamed S, Rosenheck RA et al (2011) Impact of second-generation antipsychot- ics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia. J Clin Psychiatry 72(1): 75–80

    Article  PubMed  CAS  Google Scholar 

  • Citrome L (2011) A systematic review of meta-analyses of the efficacy of oral atypical antipsychot- ics for the treatment of adult patients with schizophrenia. Expert Opin Pharmacother 13(11): 1545–1573

    Article  PubMed  Google Scholar 

  • Correll CU, Rummel-Kluge C, Corves C et al (2009) Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Schizophr Bull 35(2): 443–457

    Article  Google Scholar 

  • DGPPN (Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde) (Hrsg) (2006) Behandlungsleitlinie Schizophrenie. Reihe: S3 Praxisleitlinien in Psychiatrie und Psychotherapie, Bd 1. Springer, Berlin Heidelberg New York

    Google Scholar 

  • DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (2012) S3-Leitlinie/Nationale Versorgungsleitlinie Unipolare Depression; Langfassung Version 1.3. Januar, basierend auf der Fassung von November 2009. AWMF-Register-Nr. nvl-005

    Google Scholar 

  • Dickerson FB, Lehman AF (2011) Evidence-based psychotherapy for schizophrenia: 2011 update.J Nerv Ment Dis 199(8): 520–526

    Article  PubMed  Google Scholar 

  • Gaebel W, Riesbeck M, Wölwer W et al; German Study Group on First-Episode Schizophrenia (2011) Relapse prevention in first-episode schizophrenia - maintenance vs intermittent drug treat- ment with prodrome-based early intervention: results of a randomized controlled trial with- in the German Research Network on Schizophrenia. J Clin Psychiatry 72(2): 205–218

    Article  Google Scholar 

  • Ho BC, Andreasen NC, Ziebell S et al (2011) Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 68(2): 128–137

    Article  Google Scholar 

  • Hui WK, Mitchell LB, Kavanagh KM et al (1990) Melperone: electrophysiologic and antiarrhythmic activity in humans. J Cardiovasc Pharmacol 15: 144–149

    Article  PubMed  CAS  Google Scholar 

  • Kales HC, Kim HM, Zivin K et al (2012) Risk of mortality among individual antipsychotics in patients with dementia. Am J Psychiatry 169(1): 71–79

    PubMed  Google Scholar 

  • Kelly TM, Daley DC, Douaihy AB (2012) Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav 37(1): 11–24

    Article  PubMed  Google Scholar 

  • Kinon BJ, Chen L, Ascher-Svanum H et al (2010) Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia. Neuropsychop- harmacology 35: 581–590

    Google Scholar 

  • Kishimoto T, Agarwal V, Kishi T et al (2011) Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsy- chotics. Mol Psychiatry, Epub ahead of print

    Google Scholar 

  • Klosterkötter J, Schultze-Lutter F, Bechdolf A, Ruhrmann S (2011) Prediction and prevention of schizophrenia: what has been achieved and where to go next? World Psychiatry 10(3): 165–174

    PubMed  Google Scholar 

  • Leucht S, Corves C, Arbter D et al (2009) Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373: 31–41

    Article  PubMed  CAS  Google Scholar 

  • Leucht C, Heres S, Kane JM et al (2011) Oral versus depot antipsychotic drugs for schizophrenia - a critical systematic review and meta-analysis of randomised long-term trials. Schizophr Res. 127(1-3): 83–92

    Article  PubMed  Google Scholar 

  • Maayan L, Vakhrusheva J, Correll CU (2010) Effectiveness of medications used to attenuate antip- sychotic-related weight gain and metabolic abnormalities: a systematic review and meta- analysis. Neuropsychopharmacology 35(7): 1520–1530

    Article  Google Scholar 

  • Naber D, Lambert M (2009) The CATIE and CUtLASS studies in schizophrenia: results and implications for clinicians. CNS Drugs 23(8): 649–659

    PubMed  Google Scholar 

  • Porcelli S, Balzarro B, Serretti A (2012) Clozapine resistance: augmentation strategies. Eur Neuropsychopharmacol 22(3): 165–182

    Article  PubMed  CAS  Google Scholar 

  • Ray WA, Chung CP, Murray KT et al (2009) Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 360(3): 225–235

    Article  PubMed  CAS  Google Scholar 

  • Röder V, Mueller DR, Schmidt SJ (2011) Effectiveness of integrated psychological therapy (IPT) for schizophrenia patients: a research update. Schizophr Bull 37(Suppl 2): S71–79

    Article  PubMed  Google Scholar 

  • Rummel-Kluge C, Komossa K, Schwarz S et al (2010) Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res 123(2-3): 225–233

    Article  PubMed  Google Scholar 

  • Rummel-Kluge C, Komossa K, Schwarz S et al (2012) Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons. Schizophr Bull 38(1): 167–177

    Article  PubMed  Google Scholar 

  • Steinert T, Baier H, Fröscher W, Jandl M (2011) Epileptische Anfälle unter der Behandlung mit Antidepressiva und Neuroleptika. Fortschr Neurol Psychiatr 79(3): 138–143

    Article  PubMed  CAS  Google Scholar 

  • Tiihonen J, Haukka J, Taylor M et al (2011) A nationwide cohort study of oral and depot anti- psychotics after first hospitalization for schizophrenia. Am J Psychiatry 168(6): 603–609

    Article  PubMed  Google Scholar 

  • Tiihonen J, Suokas JT, Suvisaari JM et al (2012) Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry 69: 476–483

    Article  PubMed  CAS  Google Scholar 

  • Wenzel-Seifert K, Wittmann M, Haen E (2011) QTc prolongation by psychotropic drugs and the risk of Torsades de Pointes. Dtsch Arztebl Int 108(41): 687–693

    PubMed  Google Scholar 

  • Wolter DK (2009) Risiken von Antipsychotika im Alter, speziell bei Demenzen. Z Gerontopsychol -psychiatrie 22(1): 17–56

    Article  Google Scholar 

  • Zhang R, Dong L, Shao F et al (2011) Antipsychotics and venous thromboembolism risk: a meta- analysis. Pharmacopsychiatry 44(5): 183–188

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mainz

    Prof. Dr. med. Otto Benkert

  2. München

    Prof. Dr. med. Hanns Hippius

Authors
  1. Prof. Dr. med. Otto Benkert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Hanns Hippius
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Benkert, O., Hippius, H. (2013). Antipsychotika. In: Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29810-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-29810-3_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-29809-7

  • Online ISBN: 978-3-642-29810-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation